Skip to main content
. 2023 Apr 10;12(4):735. doi: 10.3390/antibiotics12040735

Figure 1.

Figure 1

Effects of ZnPor treatment in a mouse model of PsA pulmonary infection. The capacity of ZnPor (12.5 µg delivered) to reduce PsA pulmonary infection was tested in wild-type mice (n = 5–7 mice/group, repeated twice). Bacterial load analysis for (A) BAL and (B) lung homogenates. Measurements in BAL for (C) cell count, (D) red blood cells, and (E) platelets. * p < 0.05, Mann–Whitney U test. BAL, bronchoalveolar lavage; plts, platelets; RBC, red blood cells; NS, not significant.